Acute necrotizing esophagitis (ANE) is a severe form of acute esophagitis that appears dark black in color (”black esophagus”) at endoscopy due to mucosal necrosis [ 1 ]. ANE is an uncommon condition of unknown etiology. Grudell et al. reported that among 52 cases of ANE, seven cases involved massive gastroesophageal reflux [ 2 ]. As gastroesophageal reflux is one of the proposed causes of ANE [ 3 ] [ 4 ], treatment generally includes administration of a proton pump inhibitor (PPI). A 67-year-old man complained of vomiting and chest pain 5 days after surgery for a vitreous hemorrhage. The patient had a history of diabetes mellitus, hypertension, hyperlipidaemia, and angina pectoris. Endoscopy revealed a black-appearing esophageal mucosa extending from the proximal two thirds of the esophagus to the cardia ([ Fig. 1 ]). After 6 days of treatment that included oral nutritional rest for 1 week and rabeplazole (20 mg/day), the mucosal surface was diffusely covered with whitish exudates ([ Fig. 2 ]), and biopsy specimens consisted of necrotic debris. By continuing to take rabeplazole for 4 months after release from hospital, the patient was cured of esophagitis ([ Fig. 3 ]). However, 37 days after finishing the rabeplazole treatment, the patient returned due to recurring vomiting and chest pain. Endoscopy revealed a reoccurrence of the black-appearing esophageal mucosa and whitish exudates, as well as mucosal bleeding ([ Fig. 4 ]). Upon reestablishment of the treatment described previously, the relapsed ANE improved considerably within 3 weeks. With continued administration of rabeplazole, the ANE has not relapsed. Fig. 1 Endoscopy revealed a black-appearing esophageal mucosa extending from the proximal two thirds of the esophagus to the cardia. Fig. 2 After 6 days of treatment, the esophageal surface was diffusely covered with whitish exudates. Fig. 3 By continuing to take rabeplazole for 4 months after release from hospital, the patient was cured of esophagitis. Fig. 4 The patient returned 37 days after finishing the rabeplazole treatment, and endoscopy revealed a reoccurrence of the black-appearing esophageal mucosa and whitish exudates, as well as mucosal bleeding. To our knowledge, this is the first reported case of a relapse of ANE [ 2 ] [ 5 ]. In this case, relapse may have been associated with acid backflow, and we hypothesize that if the patient were to discontinue the PPI, he would experience another relapse. Endoscopy_UCTN_Code_CCL_1AB_2AC_3AD